Back to UBS Group AG UBS Group AG

JSPRJSPR
9 quarters

Position history for UBS Group AGUBS Group AG's holdings in JASPER THERAPEUTICS INC

UBS Group AG holds 58,759 shares of JSPR (JASPER THERAPEUTICS INC), worth $24,737 as of 2026-Q2. The position was decreased (-27.6% shares).

Current Value

$24,737

Current Shares

58,759

Total Value Change

-$67,243

Total Shares Change

+54,707

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
58,759
-27.6%
$24,7370.0%$0.42
0
2026-Q1
Decreased
81,117
-35.8%
$71,0580.0%$1.33
0
2025-Q4
Increased
126,361
+221.1%
$231,2400.0%$1.79
25
2025-Q3
Decreased
39,354
-90.5%
$93,6620.0%$2.49
0
2025-Q2
Decreased
416,275
-22.1%
$2.3M0.0%$5.49
0
2025-Q1
Increased
534,636
+225.4%
$2.3M0.0%$4.46
42
2024-Q4
Increased
164,315
+2990.4%
$3.5M0.0%$20.95
43
2024-Q3
Increased
5,317
+31.2%
$100,0130.0%$18.83
19
2024-Q2
New
4,052
-
$91,9800.0%$22.70
33

Other major holders of JSPR: Carlyle Group Inc., FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used